January 25, 2008 - The presence of emphysema seen on low-radiation-dose CT (LDCT) images appears to be an independent risk factor for lung cancer, investigators report in the December issue of Chest.

"Lung cancer screening using low-radiation-dose CT is a promising strategy currently undergoing intensive research efforts," note Javier J. Zulueta, M.D., the University of Navarra, Spain, and colleagues. "An important aspect of these strategies is the ability to identify patients at high risk for lung cancer who may benefit the most from smoking cessation treatments, early diagnosis or chemoprevention."

The researchers examined the significance of emphysema detected on LDCT of the chest using data from a prospective cohort of 1,166 former and current smokers enrolled in a lung cancer screening study. The participants underwent a baseline LDCT and spirometry followed by annual repeat LDCT studies for up to five years.

Emphysema was detected on 29 percent of the baseline LDCTs. Twenty-five percent of patients had airway obstruction on spirometry. Of the patients with emphysema on CT, 53 percent had no airway obstruction.

Overall, 23 subjects were diagnosed with lung cancer. Of these, 17 cases were detected on baseline screening, and six were detected on annual repeat screening.

Results of univariate analysis showed that the incidence of lung cancer among subjects with and without emphysema on LDCT was 25.0 per 1,000 person years and 7.5 per 1,000 person years, respectively (risk ratio, 3.33).

"In the stratified analysis, the presence of emphysema on LDCT was associated with an increased likelihood of a lung cancer diagnosis among subjects without airway obstruction (RR, 4.33)," Dr. Zulueta and colleagues report. "When the analysis was limited to participants with airway obstruction on spirometry, no relationship between emphysema on LDCT and lung cancer risk was found."

Multivariate analysis showed that the presence of emphysema on LDCT was associated with an increased risk of lung cancer after adjusting for potential confounders (RR, 2.51). Airway obstruction was not independently associated with an increased lung cancer risk.

The investigators conclude that "emphysema on LDCT is an independent risk factor for lung cancer." If the results are confirmed, "this information can be used to select candidates for lung cancer screening or chemoprevention trials."

Source: By Reuters Health, January 10, 2008

For more information: www.reutershealth.com


Related Content

News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Pediatric Imaging

June 25, 2024 — Rady Children’s Hospital-San Diego, one of the nation’s top pediatric health care systems, today ...

Time June 25, 2024
arrow
News | Artificial Intelligence

June 18, 2024 — The advancement of Artificial Intelligence (AI) in healthcare to support diagnostic decision making ...

Time June 18, 2024
arrow
News | Artificial Intelligence

June 5, 2024 — Nano-X Imaging, an innovative medical imaging technology company, today announced that its deep-learning ...

Time June 05, 2024
arrow
Subscribe Now